A. How comfortable are you in calculating the amount of a genome has been sequenced from the coverage? For example, How many of the ~120 million nucleotides in the Drosophila genome would you expect to have been sequenced if the coverage were 10x?
B. Do you have any remaining issues regarding Myers et al that warrent discussion?
A. There will be a talk/discussion Friday, February 25, some time between 9AM and 11AM, by David Harper, Chief Scientific Officer of BioControl a subsidiary of Targeted Genetics. He is the founder of his company, which has the goal of targeting bacteriophage to human pathogens. You can read a bit more here about BioControl's approach and Sulakvelidze et al (2001) for a general account of phage therapy.
- Would you be interested and able to attend?
- Do you have a preference as to the format and nature of the encounter? He is willing to give a conventional talk or lead a more informal discussion of biotechnology and your possible roles in it.
B. Any miscellaneous comments, questions, suggestions, concerns?